研究抗體市場規模、份額和趨勢報告:按產品(初級、次級)、類型、技術、原材料、應用、最終用途、地區、細分市場、預測 2022-2030
市場調查報告書
商品編碼
1133279

研究抗體市場規模、份額和趨勢報告:按產品(初級、次級)、類型、技術、原材料、應用、最終用途、地區、細分市場、預測 2022-2030

Research Antibodies Market Size, Share & Trends Analysis Report By Product (Primary, Secondary), By Type, By Technology, By Source, By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

研究抗體市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告,預計 2022 年至 2030 年全球研究抗體市場規模將以 4.93% 的複合年增長率增長,到 2030 年將達到 22.1 億美元的增長。市場驅動因素包括生物製藥和生物技術公司增加研發活動以及政府當局增加支持。此外,擴大神經生物學和乾細胞研究的覆蓋範圍以及利用技術先進的抗體製造方法有望推動市場增長。

研究機構和各種公共和私人組織為促進基於細胞的研究而採取的越來越多的聯合舉措正在推動市場的增長。這種趨勢在北美等科學基礎設施成熟的市場更為明顯。例如,2020年3月,加拿大政府向再生醫學商業化中心投資約430萬美元,該中心將參與開展基於細胞再生的科學研究。此外,幹細胞網絡將於 2021 年 4 月啟動,為 COVID-19 等慢性和嚴重疾病患者開發信息、治療和技術,並評估其長期影響。宣佈在三年內投資 4500 萬美元。預計此類努力將促進進一步引入抗體活動並增強市場的增長前景。

COVID-19 的爆發正在為市場創造有利可圖的增長機會。幾家大型製藥公司已在研發方面投入巨資,以創建有效的測試工具並促進對該疾病的科學認識。由於為開發新疫苗和治療技術而進行的大量研究和開發工作,對研究抗體的需求顯著增加。此外,許多公共和商業組織正在大力資助 COVID-19 疫苗和療法的開發。例如,2020 年 4 月,生物製藥公司 Emergent BioSolutions 從聯邦政府獲得了 1450 萬美元,用於 COVID-19 的抗體治療研究。

研究抗體市場報告亮點

2021年,由於抗體提供的高特異性和直接檢測能力,初級產品部分佔銷售額的最大份額

按類型劃分,由於涉及使用此類抗體的 COVID-19 相關研究活動增加,單克隆抗體在 2021 年獲得了顯著份額

由於多家生物技術和製藥公司對研發活動的投資增加,以及用於蛋白質組學研究的蛋白質印跡抗體的使用迅速擴大,Western Blotting Technologies 部門將在 2021 年增長。獲得 25.0% 或更多的壓倒性市場份額

按最終用戶劃分,由於資助機會增加和更多科學機構參與生命科學,學術和研究機構在 2021 年佔最大份額,超過 60.0%。

到 2021 年,北美將佔最大份額,超過 35.0%,廣泛分佈著生命科學研究機構和眾多生物技術和生物製藥製造商

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
  • 市場定義
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息和第三方觀點
    • 初步調查
  • 信息分析
    • 數據分析模型
  • 市場形成和數據可視化
  • 驗證和發布數據

第二章執行摘要

  • 市場展望
  • 分部展望

3 研究抗體市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力分析
      • 加大研發投入
      • 探索幹細胞增殖和神經生物學
      • 加強研究學院和工業界之間的合作
      • 技術先進產品的可用性增加
      • 蛋白質組學和基因組學研究的興起
    • 市場製約因素及挑戰分析
      • 不確定的政府監管
      • 與研究抗體相關的質量問題以及耗時且昂貴的抗體開發過程
    • 市場機會分析
      • 對個性化醫療的需求不斷增長,對生物標誌物發現的興趣日益濃厚
      • 各種新興市場的機會增加
  • 研究抗體市場分析工具
    • 行業分析 - 搬運工
      • 供應商力量
      • 買方議價能力
      • 替代威脅
      • 來自新進入者的威脅
      • 競爭對手之間的競爭
    • PESTEL 分析
  • COVID-19 對研究抗體市場的影響

第 4 章研究抗體市場:產品估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年產品市場份額分析
  • 細分儀表板
  • 2018-2030 年按產品分列的全球研究抗體市場
  • 2018-2030年市場規模及預測,趨勢分析
  • 基本的
  • 中學

第 5 章研究抗體市場:類型估計和趨勢分析

  • 定義和範圍
  • 類型市場份額分析,2021 年和 2030 年
  • 細分儀表板
  • 2018-2030 年按類型分列的全球研究抗體市場
  • 2018-2030年市場規模及預測,趨勢分析
  • 單克隆抗體
  • 多克隆抗體

第 6 章用於研究的抗體市場:技術估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年技術市場份額分析
  • 細分儀表板
  • 按市場、技術,2018-2030
  • 2018-2030年市場規模及預測,趨勢分析
  • 免疫化學
  • 免疫熒光
  • 免疫印跡
  • 流式細胞儀
  • 免疫沉澱
  • □聯免疫吸附試驗
  • 其他技術

第 7 章研究抗體市場:原材料估計和趨勢分析

  • 定義和範圍
  • 來源市場份額分析,2021 年和 2030 年
  • 細分儀表板
  • 按市場,來源,2018-2030
  • 2018-2030年市場規模及預測,趨勢分析
  • 兔子
  • 山羊
  • 其他原材料

8 研究抗體市場:應用估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年應用市場份額分析
  • 細分儀表板
  • 2018-2030 年按應用分列的全球研究抗體市場
  • 2018-2030年市場規模及預測,趨勢分析
  • 感染
  • 免疫學
  • 腫瘤學
  • 幹細胞
  • 神經生物學
  • 其他應用

9 研究抗體市場:最終用途估計和趨勢分析

  • 定義和範圍
  • 2021 年和 2030 年最終用途市場份額分析
  • 細分儀表板
  • 市場,按最終用途,2018-2030
  • 2018-2030年市場規模及預測,趨勢分析
  • 學術/研究機構
  • 委託研究機構
  • 製藥和生物技術公司

10 研究抗體市場:細分分析,按地區,2018-2030 年(百萬美元)

  • 研究抗體市場:2021 年和 2030 年區域趨勢分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 意大利
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 11 章 競爭格局

  • 上市公司
    • 公司市場分析
    • 競爭儀錶盤分析
    • 戰略框架
  • 民營企業
    • 關鍵初創企業/技術顛覆者/創新者名單
    • 區域網絡圖
  • 公司簡介
    • ABCAM PLC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • MERCK KGAA
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • THERMO FISHER SCIENTIFIC, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • CELL SIGNALLING TECHNOLOGY, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • SANTA CRUZ BIOTECHNOLOGY INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • PERKINELMER, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • BECTON, DICKINSON &COMPANY
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • BIO-TECHNE CORPORATION
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • PROTEINTECH GROUP, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • JACKSON IMMUNORESEARCH INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-2-68038-124-5

Research Antibodies Market Growth & Trends:

The global research antibodies market size is expected to reach USD 2.21 billion by 2030, expanding at a CAGR of 4.93% from 2022 to 2030, according to a new report by Grand View Research, Inc. Factors driving the market include a rise in R&D activities undertaken by biopharmaceutical and biotechnology companies and increase in support from government authorities. Furthermore, expansion in the scope of neurobiology and stem cell research and the availability of technologically advanced antibody production methods are expected to propel market growth.

An increase in the number of collaborative initiatives undertaken by research institutes and various public and private entities for the promotion of cell-based research is fueling market growth. The trend is more prominent in established markets, such as North America, that have an established scientific infrastructure. For instance, in March 2020, the Canadian government invested around USD 4.3 million in funds towards the Centre for Commercialization of Regenerative Medicine, which is involved in carrying out scientific studies based on cell regeneration. Moreover, in April 2021, the government announced an investment of USD 45 million over 3 years in Stem Cell Network to develop information, therapies, and technologies to benefit individuals living with chronic and severe illnesses such as COVID-19 and assess its long-term impact. Such initiatives are expected to encourage further adoption of antibody activities and enhance the growth prospects for the market.

The COVID-19 outbreak has created lucrative growth opportunities for the market. Several leading pharmaceutical companies are investing significantly in R&D for creating effective testing tools and increasing scientific understanding of the disease. The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19.

Research Antibodies Market Report Highlights:

  • In 2021, the primary product segment held the largest revenue share due to the higher specificity and direct detection capabilities offered by the antibodies
  • By type, monoclonal antibodies captured a substantial share in 2021 due to the increase in COVID-19-related research activities involving the use of such antibodies
  • The western blotting technology segment held a dominant share of over 25.0% in 2021 because of the increasing investments in R&D activities by several biotechnology and pharmaceutical companies and the rapidly growing applications of antibodies in western blots created for proteomic studies
  • By end-use, academic and research institutions held the largest share of over 60.0% in 2021 due to a rise in funding opportunities and growth in the number of scientific institutions involved in life sciences
  • In 2021, North America accounted for the largest share of over 35.0% due to the widespread presence of life sciences research institutions and numerous biotechnology and biopharmaceutical manufacturers in the region

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources & Third Party Perspectives
    • 1.3.4 Primary Research
  • 1.4 Information Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Research Antibodies Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Increasing Investment In R&D
      • 3.3.1.2 Growing Stem Cells And Neurobiology Research
      • 3.3.1.3 Increase In Research Academies And Industry Collaborations
      • 3.3.1.4 Rise In The Availability Of Technologically Advanced Products
      • 3.3.1.5 Rise In Proteomics And Genomics Research
    • 3.3.2 Market Restraint and Challenges Analysis
      • 3.3.2.1 Uncertain Government Regulations
      • 3.3.2.2 Quality Concerns associated with research antibodies and time- & cost-intensive process of antibody development
    • 3.3.3 Market Opportunities Analysis
      • 3.3.3.1 Growing demand for Personalized medicine and rising focus on biomarker discovery
      • 3.3.3.2 Increasing opportunities in various emerging markets
  • 3.4 Research Antibodies Market Analysis Tools
    • 3.4.1 Industry Analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat From New Entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
  • 3.5 Covid-19 Impact On Research Antibodies Market

Chapter 4 Research Antibodies Market: Product Estimates And Trend Analysis

  • 4.1 Definition & Scope
  • 4.2 Product Market Share Analysis, 2021 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Research Antibodies Market, By Product, 2018 To 2030
  • 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 4.6 Primary
    • 4.6.1 Primary Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 4.7 Secondary
    • 4.7.1 Secondary Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 5 Research Antibodies Market: Type Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Type Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Research Antibodies Market, By Type, 2018 To 2030
  • 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 5.6 Monoclonal Antibodies
    • 5.6.1 Monoclonal Antibodies Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 5.7 Polyclonal Antibodies
    • 5.7.1 Polyclonal Antibodies Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 6 Research Antibodies Market: Technology Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Technology Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Market, By Technology, 2018 To 2030
  • 6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 6.6 Immunochemistry
    • 6.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 6.7 Immunofluorescence
    • 6.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 6.8 Western Blotting
    • 6.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 6.9 Flow Cytometry
    • 6.9.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 6.10 Immunoprecipitation
    • 6.10.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 6.11 ELISA
    • 6.11.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 6.12 Other Technologies
    • 6.12.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 7 Research Antibodies Market: Source Estimates And Trend Analysis

  • 7.1 Definition & Scope
  • 7.2 Source Market Share Analysis, 2021 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Market, By Source, 2018 To 2030
  • 7.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 7.6 Mouse
    • 7.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 7.7 Rabbit
    • 7.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 7.8 Goat
    • 7.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 7.9 Other Sources
    • 7.9.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 8 Research Antibodies Market: Application Estimates And Trend Analysis

  • 8.1 Definition & Scope
  • 8.2 Application Market Share Analysis, 2021 & 2030
  • 8.3 Segment Dashboard
  • 8.4 Global Research Antibodies Market, By Application, 2018 To 2030
  • 8.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 8.6 Infectious Diseases
    • 8.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 8.7 Immunology
    • 8.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 8.8 Oncology
    • 8.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 8.9 Stem Cells
    • 8.9.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 8.10 Neurobiology
    • 8.10.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 8.11 Other Applications
    • 8.11.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 9 Research Antibodies Market: End-use Estimates And Trend Analysis

  • 9.1 Definition & Scope
  • 9.2 End-use Market Share Analysis, 2021 & 2030
  • 9.3 Segment Dashboard
  • 9.4 Market, By End Use, 2018 To 2030
  • 9.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 9.6 Academic & Research Institutes
    • 9.6.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 9.7 Contract Research Organizations
    • 9.7.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)
  • 9.8 Pharmaceutical & Biotechnology Companies
    • 9.8.1 Market Estimates And Forecasts, 2018 To 2030 (USD Million)

Chapter 10 Research Antibodies Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 10.1 Research Antibodies Market: Regional Movement Analysis, 2021 & 2030
  • 10.2 North America
    • 10.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.2.2 U.S.
      • 10.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.2.3 Canada
      • 10.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.3 Europe
    • 10.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.3.2 U.K.
      • 10.3.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 10.3.3 Germany
      • 10.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.3.4 Spain
      • 10.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.3.5 France
      • 10.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.3.6 Italy
      • 10.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.3.7 Russia
      • 10.3.7.1 Russia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.2 Japan
      • 10.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.3 China
      • 10.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.4.4 India
      • 10.4.4.1 India Market Estimates And Forecast, 2018 - 2030
    • 10.4.5 South Korea
      • 10.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
    • 10.4.6 Australia
      • 10.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030
    • 10.4.7 Singapore
      • 10.4.7.1 Singapore Market Estimates And Forecast, 2018 - 2030
  • 10.5 Latin America
    • 10.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.2 Brazil
      • 10.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.3 Mexico
      • 10.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.5.4 Argentina
      • 10.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 10.6 Middle East & Africa (MEA)
    • 10.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.6.2 South Africa
      • 10.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.6.3 Saudi Arabia
      • 10.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 10.6.4 UAE
      • 10.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 11 Competitive Landscape

  • 11.1 Public Companies
    • 11.1.1 Company Market Position Analysis
    • 11.1.2 Competitive Dashboard Analysis
    • 11.1.3 Strategic Framework
  • 11.2 Private Companies
    • 11.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 11.2.2 Regional Network Map
  • 11.3 Company Profiles
    • 11.3.1 ABCAM PLC
      • 11.3.1.1 Company Overview
      • 11.3.1.2 Financial Performance
      • 11.3.1.3 Product Benchmarking
      • 11.3.1.4 Strategic Initiatives
    • 11.3.2 MERCK KGAA
      • 11.3.2.1 Company Overview
      • 11.3.2.2 Financial Performance
      • 11.3.2.3 Product Benchmarking
      • 11.3.2.4 Strategic Initiatives
    • 11.3.3 THERMO FISHER SCIENTIFIC, INC.
      • 11.3.3.1 Company Overview
      • 11.3.3.2 Financial Performance
      • 11.3.3.3 Product Benchmarking
      • 11.3.3.4 Strategic Initiatives
    • 11.3.4 CELL SIGNALLING TECHNOLOGY, INC.
      • 11.3.4.1 Company Overview
      • 11.3.4.2 Financial Performance
      • 11.3.4.3 Product Benchmarking
      • 11.3.4.4 Strategic Initiatives
    • 11.3.5 SANTA CRUZ BIOTECHNOLOGY INC.
      • 11.3.5.1 Company Overview
      • 11.3.5.2 Financial Performance
      • 11.3.5.3 Product Benchmarking
      • 11.3.5.4 Strategic Initiatives
    • 11.3.6 PERKINELMER, INC.
      • 11.3.6.1 Company Overview
      • 11.3.6.2 Financial Performance
      • 11.3.6.3 Product Benchmarking
      • 11.3.6.4 Strategic Initiatives
    • 11.3.7 BECTON, DICKINSON & COMPANY
      • 11.3.7.1 Company Overview
      • 11.3.7.2 Financial Performance
      • 11.3.7.3 Product Benchmarking
      • 11.3.7.4 Strategic Initiatives
    • 11.3.8 BIO-TECHNE CORPORATION
      • 11.3.8.1 Company Overview
      • 11.3.8.2 Financial Performance
      • 11.3.8.3 Product Benchmarking
      • 11.3.8.4 Strategic Initiatives
    • 11.3.9 PROTEINTECH GROUP, INC.
      • 11.3.9.1 Company Overview
      • 11.3.9.2 Financial Performance
      • 11.3.9.3 Product Benchmarking
      • 11.3.9.4 Strategic Initiatives
    • 11.3.10 JACKSON IMMUNORESEARCH INC.
      • 11.3.10.1 Company Overview
      • 11.3.10.2 Financial Performance
      • 11.3.10.3 Product Benchmarking
      • 11.3.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 6 Global Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7 Global Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 8 Global Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 9 Global Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 Global Research Antibodies Market, by Region, 2018 - 2030 (USD Million)
  • Table 11 North America Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 12 North America Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 North America Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 14 North America Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 15 North America Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 North America Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 17 U.S. Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.S. Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 U.S. Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20 U.S. Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 21 U.S. Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 22 U.S. Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 Canada Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Canada Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Canada Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 26 Canada Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 27 Canada Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Canada Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Europe Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Europe Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Europe Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Europe Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 33 Europe Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Europe Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 U.K. Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 U.K. Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 U.K. Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 U.K. Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 39 U.K. Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 U.K. Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 Germany Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Germany Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Germany Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Germany Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 45 Germany Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Germany Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 47 France Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 France Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 49 France Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 France Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 51 France Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 France Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 53 Italy Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Italy Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Italy Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 Italy Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 57 Italy Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Italy Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 59 Spain Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Spain Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 61 Spain Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Spain Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 63 Spain Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Spain Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 65 Russia Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 66 Russia Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Russia Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 68 Russia Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 69 Russia Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Russia Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Japan Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Japan Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 79 Japan Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 80 Japan Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 81 Japan Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 82 Japan Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 83 China Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 China Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 China Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 China Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 87 China Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 88 China Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 89 India Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 India Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 India Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 India Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 93 India Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 India Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 95 South Korea Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 96 South Korea Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 South Korea Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 South Korea Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 99 South Korea Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 South Korea Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 101 Australia Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Australia Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 103 Australia Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 104 Australia Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 105 Australia Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Australia Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 107 Singapore Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 108 Singapore Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 109 Singapore Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 110 Singapore Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 111 Singapore Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 Singapore Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 113 Latin America Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Latin America Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 115 Latin America Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Latin America Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 117 Latin America Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 118 Latin America Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 119 Brazil Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 120 Brazil Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 121 Brazil Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 122 Brazil Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 123 Brazil Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 124 Brazil Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 125 Mexico Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 Mexico Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 127 Mexico Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 128 Mexico Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 129 Mexico Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 130 Mexico Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 131 Argentina Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 Argentina Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 133 Argentina Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 134 Argentina Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 135 Argentina Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 136 Argentina Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 137 MEA Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 138 MEA Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 139 MEA Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 140 MEA Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 141 MEA Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 142 MEA Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 143 South Africa Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 144 South Africa Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 145 South Africa Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 146 South Africa Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 147 South Africa Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 148 South Africa Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 149 Saudi Arabia Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 150 Saudi Arabia Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 151 Saudi Arabia Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 152 Saudi Arabia Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 153 Saudi Arabia Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 154 Saudi Arabia Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)
  • Table 155 UAE Research Antibodies Market, by Product, 2018 - 2030 (USD Million)
  • Table 156 UAE Research Antibodies Market, by Type, 2018 - 2030 (USD Million)
  • Table 157 UAE Research Antibodies Market, by Technology, 2018 - 2030 (USD Million)
  • Table 158 UAE Research Antibodies Market, by Source, 2018 - 2030 (USD Million)
  • Table 159 UAE Research Antibodies Market, by Application, 2018 - 2030 (USD Million)
  • Table 160 UAE Research Antibodies Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information Procurement
  • Figure 3 Primary Research Pattern
  • Figure 4 Market Research Approaches
  • Figure 5 Value Chain-Based Sizing & Forecasting
  • Figure 6 Market Formulation & Validation
  • Figure 7 Research Antibodies, Market Segmentation
  • Figure 8 Market Snapshot, 2021
  • Figure 9 Market Trends & Outlook
  • Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Figure 13 Porter's Five Forces Analysis
  • Figure 14 Market Penetration Vs Growth Prospect Mapping, 2021
  • Figure 15 Global Research Antibodies Market: Product Movement Analysis
  • Figure 16 Global Research Antibodies Market, for Primary, 2018 - 2030 (USD Million)
  • Figure 17 Global Research Antibodies Market, for Secondary, 2018 - 2030 (USD Million)
  • Figure 18 Global Research Antibodies Market: Type, Movement Analysis
  • Figure 19 Global Research Antibodies Market, for Monoclonal Antibodies, 2018 - 2030 (USD Million)
  • Figure 20 Global Research Antibodies Market, for Polyclonal Antibodies, 2018 - 2030 (USD Million)
  • Figure 21 Global Research Antibodies Market: Technology, Movement Analysis
  • Figure 22 Global Research Antibodies Market, for Immunohistochemistry, 2018 - 2030 (USD Million)
  • Figure 23 Global Research Antibodies Market, for Immunofluorescence, 2018 - 2030 (USD Million)
  • Figure 24 Global Research Antibodies Market, for Western Blotting, 2018 - 2030 (USD Million)
  • Figure 25 Global Research Antibodies Market, for Flow Cytometry, 2018 - 2030 (USD Million)
  • Figure 26 Global Research Antibodies Market: Immunoprecipitation, Movement Analysis
  • Figure 27 Global Research Antibodies Market, for ELISA, 2018 - 2030 (USD Million)
  • Figure 28 Global Research Antibodies Market, for Other Technologies, 2018 - 2030 (USD Million)
  • Figure 29 Global Research Antibodies Market: Source, Movement Analysis
  • Figure 30 Global Research Antibodies Market, for Mouse, 2018 - 2030 (USD Million)
  • Figure 31 Global Research Antibodies Market, for Rabbit, 2018 - 2030 (USD Million)
  • Figure 32 Global Research Antibodies Market, for Goat, 2018 - 2030 (USD Million)
  • Figure 33 Global Research Antibodies Market, for Other Sources, 2018 - 2030 (USD Million)
  • Figure 34 Global Research Antibodies Market: Application, Movement Analysis
  • Figure 35 Global Research Antibodies Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Figure 36 Global Research Antibodies Market, for Immunology, 2018 - 2030 (USD Million)
  • Figure 37 Global Research Antibodies Market, for Oncology, 2018 - 2030 (USD Million)
  • Figure 38 Global Research Antibodies Market, for Stem Cells, 2018 - 2030 (USD Million)
  • Figure 39 Global Research Antibodies Market, for Neurobiology, 2018 - 2030 (USD Million)
  • Figure 40 Global Research Antibodies Market, for Other Applications, 2018 - 2030 (USD Million)
  • Figure 41 Global Research Antibodies Market: End-use, Movement Analysis
  • Figure 42 Global Research Antibodies Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Figure 43 Global Research Antibodies Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
  • Figure 44 Global Research Antibodies Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Figure 45 Regional Marketplace: Key Takeaways
  • Figure 46 Regional Outlook, 2021 & 2030
  • Figure 47 Global Research Antibodies Market: Region Movement Analysis
  • Figure 48 North America Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 49 U.S. Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 50 Canada Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 51 Europe Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 52 Germany Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 53 U.K. Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 54 France Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 55 Italy Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 56 Spain Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 57 Russia Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 58 Asia Pacific Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 59 Japan Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 60 China Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 61 India Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 62 Australia Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 63 South Korea Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 64 Singapore Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 65 Latin America Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 66 Brazil Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 67 Mexico Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 68 Argentina Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 69 Middle East and Africa Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 70 South Africa Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 71 Saudi Arabia Research Antibodies Market, 2018 - 2030 (USD Million)
  • Figure 72 UAE Research Antibodies Market, 2018 - 2030 (USD Million)